136 related articles for article (PubMed ID: 8692016)
1. Postprandial reduction in high-density lipoprotein cholesterol concentrations in postmenopausal women: improvement by 17beta-estradiol.
Westerveld HT; Meijer E; Erkelens DW; de Bruin TW
Metabolism; 1996 Jul; 45(7):827-32. PubMed ID: 8692016
[TBL] [Abstract][Full Text] [Related]
2. Menopause is associated with reduced protection from postprandial lipemia.
van Beek AP; de Ruijter-Heijstek FC; Erkelens DW; de Bruin TW
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2737-41. PubMed ID: 10559019
[TBL] [Abstract][Full Text] [Related]
3. Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study.
Alssema M; El-Harchaoui K; Schindhelm RK; Diamant M; Nijpels G; Kostense PJ; Teerlink T; Heine RJ; Dallinga-Thie GM; Kuivenhoven JA; Dekker JM; Scheffer PG
Metabolism; 2010 Jun; 59(6):854-60. PubMed ID: 20005542
[TBL] [Abstract][Full Text] [Related]
4. 17 beta-Estradiol improves postprandial lipid metabolism in postmenopausal women.
Westerveld HT; Kock LA; van Rijn HJ; Erkelens DW; de Bruin TW
J Clin Endocrinol Metab; 1995 Jan; 80(1):249-53. PubMed ID: 7829621
[TBL] [Abstract][Full Text] [Related]
5. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
[TBL] [Abstract][Full Text] [Related]
6. Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease.
Zhao SP; Liu L; Cheng YC; Li YL
Atherosclerosis; 2003 Jun; 168(2):375-80. PubMed ID: 12801622
[TBL] [Abstract][Full Text] [Related]
7. Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.
Julius U; Fritsch H; Fritsch W; Rehak E; Fücker K; Leonhardt W; Hanefeld M
Clin Investig; 1994 Jul; 72(7):502-7. PubMed ID: 7981577
[TBL] [Abstract][Full Text] [Related]
8. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism.
De Bruin TW; Brouwer CB; Gimpel JA; Erkelens DW
Am J Physiol; 1991 Mar; 260(3 Pt 1):E492-8. PubMed ID: 1900671
[TBL] [Abstract][Full Text] [Related]
9. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women.
Granfone A; Campos H; McNamara JR; Schaefer MM; Lamon-Fava S; Ordovas JM; Schaefer EJ
Metabolism; 1992 Nov; 41(11):1193-8. PubMed ID: 1435290
[TBL] [Abstract][Full Text] [Related]
10. Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese women.
Ferrer F; Nazih H; Zaïr Y; Krempf M; Bard JM
Metabolism; 2003 Dec; 52(12):1537-41. PubMed ID: 14669151
[TBL] [Abstract][Full Text] [Related]
11. Delayed increase in high density lipoprotein-phospholipids after ingestion of a fat load in normolipidemic patients with coronary artery disease.
Groener JE; Scheek LM; van Ramshorst E; Krauss XH; van Tol A
Atherosclerosis; 1998 Apr; 137(2):311-9. PubMed ID: 9622274
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum triglycerides and high-density lipoprotein concentration and composition after a low-fat mixed meal. Effects of gender and insulin resistance.
Branchi A; Torri A; Berra C; Colombo E; Sommariva D
Intern Emerg Med; 2006; 1(4):287-95. PubMed ID: 17217150
[TBL] [Abstract][Full Text] [Related]
13. Corn oil and beef tallow elicit different postprandial responses in triglycerides and cholesterol, but similar changes in constituents of high-density lipoprotein.
Muesing RA; Griffin P; Mitchell P
J Am Coll Nutr; 1995 Feb; 14(1):53-60. PubMed ID: 7706611
[TBL] [Abstract][Full Text] [Related]
14. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
[TBL] [Abstract][Full Text] [Related]
15. A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles.
Lobo RA; Zacur HZ; Caubel P; Lane R
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):41-9. PubMed ID: 10649155
[TBL] [Abstract][Full Text] [Related]
16. Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women.
Pirro M; Lupattelli G; Siepi D; Palumbo B; Roscini AR; Marchesi S; Schillaci G; Mannarino E
Metabolism; 2001 Mar; 50(3):330-4. PubMed ID: 11230787
[TBL] [Abstract][Full Text] [Related]
17. Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.
Reitsma JB; Castro Cabezas M; de Bruin TW; Erkelens DW
Metabolism; 1994 Mar; 43(3):293-8. PubMed ID: 8139476
[TBL] [Abstract][Full Text] [Related]
18. Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study.
Campos H; Wilson PW; Jiménez D; McNamara JR; Ordovas J; Schaefer EJ
Metabolism; 1990 Oct; 39(10):1033-8. PubMed ID: 2120547
[TBL] [Abstract][Full Text] [Related]
19. Delayed postprandial retinyl palmitate and squalene removal in a patient heterozygous for apolipoprotein A-IFIN mutation (Leu 159-->Arg) and low HDL cholesterol level without coronary artery disease.
Gylling H; Relas H; Miettinen HE; Radhakrishnan R; Miettinen TA
Atherosclerosis; 1996 Dec; 127(2):239-43. PubMed ID: 9125314
[TBL] [Abstract][Full Text] [Related]
20. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
